BMXMF
Price
$140.25
Change
-$6.95 (-4.72%)
Updated
Aug 29 closing price
Capitalization
15.93B
COO
Price
$68.08
Change
+$0.08 (+0.12%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
13.54B
89 days until earnings call
Interact to see
Advertisement

BMXMF vs COO

Header iconBMXMF vs COO Comparison
Open Charts BMXMF vs COOBanner chart's image
Biomerieux 69 Marcy L'Etoile
Price$140.25
Change-$6.95 (-4.72%)
Volume$50
Capitalization15.93B
Cooper Companies (The)
Price$68.08
Change+$0.08 (+0.12%)
Volume$88.57K
Capitalization13.54B
BMXMF vs COO Comparison Chart in %
Loading...
BMXMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMXMF vs. COO commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMXMF is a Hold and COO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BMXMF: $140.25 vs. COO: $68.00)
Brand notoriety: BMXMF and COO are both not notable
BMXMF represents the Medical Specialties, while COO is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BMXMF: 26% vs. COO: 131%
Market capitalization -- BMXMF: $16.21B vs. COO: $13.52B
BMXMF [@Medical Specialties] is valued at $16.21B. COO’s [@Pharmaceuticals: Other] market capitalization is $13.52B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.57B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMXMF’s FA Score shows that 1 FA rating(s) are green whileCOO’s FA Score has 0 green FA rating(s).

  • BMXMF’s FA Score: 1 green, 4 red.
  • COO’s FA Score: 0 green, 5 red.
According to our system of comparison, BMXMF is a better buy in the long-term than COO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMXMF’s TA Score shows that 4 TA indicator(s) are bullish while COO’s TA Score has 4 bullish TA indicator(s).

  • BMXMF’s TA Score: 4 bullish, 4 bearish.
  • COO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BMXMF is a better buy in the short-term than COO.

Price Growth

BMXMF (@Medical Specialties) experienced а -4.72% price change this week, while COO (@Pharmaceuticals: Other) price change was +5.30% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.22%. For the same industry, the average monthly price growth was +6.83%, and the average quarterly price growth was +11.96%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.39%. For the same industry, the average monthly price growth was +7.03%, and the average quarterly price growth was +18.51%.

Reported Earning Dates

COO is expected to report earnings on Dec 04, 2025.

Industries' Descriptions

@Medical Specialties (+0.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-1.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMXMF($15.9B) has a higher market cap than COO($13.5B). BMXMF has higher P/E ratio than COO: BMXMF (37.38) vs COO (33.38). BMXMF YTD gains are higher at: 32.075 vs. COO (-26.031). COO has higher annual earnings (EBITDA): 1.1B vs. BMXMF (910M). BMXMF has more cash in the bank: 450M vs. COO (116M). BMXMF has less debt than COO: BMXMF (491M) vs COO (2.59B). COO (3.99B) and BMXMF (3.98B) have equivalent revenues.
BMXMFCOOBMXMF / COO
Capitalization15.9B13.5B118%
EBITDA910M1.1B83%
Gain YTD32.075-26.031-123%
P/E Ratio37.3833.38112%
Revenue3.98B3.99B100%
Total Cash450M116M388%
Total Debt491M2.59B19%
FUNDAMENTALS RATINGS
BMXMF vs COO: Fundamental Ratings
BMXMF
COO
OUTLOOK RATING
1..100
8667
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7185
PRICE GROWTH RATING
1..100
5264
P/E GROWTH RATING
1..100
2992
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMXMF's Valuation (48) in the null industry is in the same range as COO (79) in the Medical Specialties industry. This means that BMXMF’s stock grew similarly to COO’s over the last 12 months.

BMXMF's Profit vs Risk Rating (100) in the null industry is in the same range as COO (100) in the Medical Specialties industry. This means that BMXMF’s stock grew similarly to COO’s over the last 12 months.

BMXMF's SMR Rating (71) in the null industry is in the same range as COO (85) in the Medical Specialties industry. This means that BMXMF’s stock grew similarly to COO’s over the last 12 months.

BMXMF's Price Growth Rating (52) in the null industry is in the same range as COO (64) in the Medical Specialties industry. This means that BMXMF’s stock grew similarly to COO’s over the last 12 months.

BMXMF's P/E Growth Rating (29) in the null industry is somewhat better than the same rating for COO (92) in the Medical Specialties industry. This means that BMXMF’s stock grew somewhat faster than COO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMXMFCOO
RSI
ODDS (%)
Bullish Trend 2 days ago
49%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
65%
Momentum
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
59%
MACD
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
60%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
60%
Declines
ODDS (%)
Bearish Trend 16 days ago
53%
Bearish Trend 16 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
43%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
BMXMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENOV31.550.89
+2.90%
Enovis Corp
UEIC4.850.09
+1.89%
Universal Electronics
FRMEP25.84N/A
N/A
First Merchants Corp
YMAB8.57-0.01
-0.12%
Y-mAbs Therapeutics
IONS59.35-1.14
-1.88%
Ionis Pharmaceuticals

BMXMF and

Correlation & Price change

A.I.dvisor tells us that BMXMF and COO have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMXMF and COO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMXMF
1D Price
Change %
BMXMF100%
N/A
COO - BMXMF
26%
Poorly correlated
+1.28%
SOAGY - BMXMF
24%
Poorly correlated
-3.52%
BRKR - BMXMF
22%
Poorly correlated
+1.50%
MGRM - BMXMF
21%
Poorly correlated
-1.16%
CHEOF - BMXMF
7%
Poorly correlated
N/A
More

COO and

Correlation & Price change

A.I.dvisor indicates that over the last year, COO has been loosely correlated with A. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
+1.28%
A - COO
50%
Loosely correlated
+2.60%
ALC - COO
48%
Loosely correlated
+0.24%
DHR - COO
46%
Loosely correlated
-0.21%
SYK - COO
45%
Loosely correlated
+1.49%
BIO - COO
44%
Loosely correlated
+0.48%
More